Cyclodextrin Masterclass II – online, free-to-attend webinar

Cyclodextrins in biologics: current trends and future directions

January 30, 2025, 8:00 am – 8:45 am (EST) / 2:00 pm – 2:45 pm (CET)

Our webinar, entitled “Cyclodextrins in drug delivery of biologics – current trends and future directions” is the 2nd episode in a series of webinars (CarboHyde’s Cyclodextrin Masterclass) that aims to provide educative content to cyclodextrin users and researcher on various applications.

Registration form:

Event Overview: Join us for an illuminating webinar that traces the evolution of cyclodextrin-based drug delivery systems — from current mainstream applications to future trends. Our esteemed speaker will explore key aspects of this journey, highlighting breakthroughs, challenges, and the promise of cyclodextrins in improving therapeutic outcomes.

We will discuss developments 4 big areas:

– monoclonal antibodies

– gene therapy

– vaccines

– biotechnology

Agenda:

Cyclodextrins in drug delivery of biologics – current trends and future directions

Speaker: Dr. Tamas Sohajda (CarboHyde)

Tamas will unveil how cyclodextrins bridge the gap between lab experiments and clinical applications for biologics and what are the mainstream uses of CDs in various applications, such as formulation of proteins, oligos, vaccines or cells. Then we will take a glimpse into the future and explore what novel formulations may offer beyond mainstream uses.

The first event of CarboHyde Cyclodextrin Masterclass I is open for registration!

Our webinar, titled “Cyclodextrins in small molecule drug delivery – current trends and future directions” is the first episode in a series of webinars (CarboHyde’s Cyclodextrin Masterclass) that aims to provide educative content to cyclodextrin users and researcher on various applications.

Event Overview: Join us for an illuminating webinar that traces the evolution of cyclodextrin-based drug delivery systems—from current mainstream applications towards future trends. Our esteemed speaker will explore key aspects of this journey, highlighting breakthroughs, challenges, and the promise of cyclodextrins in improving therapeutic outcomes.